chr21-33027730-G-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP3_ModerateBS2
The NM_005806.4(OLIG2):c.868G>T(p.Gly290Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000038 in 1,369,430 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000033 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000039 ( 0 hom. )
Consequence
OLIG2
NM_005806.4 missense
NM_005806.4 missense
Scores
6
11
2
Clinical Significance
Conservation
PhyloP100: 7.32
Genes affected
OLIG2 (HGNC:9398): (oligodendrocyte transcription factor 2) This gene encodes a basic helix-loop-helix transcription factor which is expressed in oligodendroglial tumors of the brain. The protein is an essential regulator of ventral neuroectodermal progenitor cell fate. The gene is involved in a chromosomal translocation t(14;21)(q11.2;q22) associated with T-cell acute lymphoblastic leukemia. Its chromosomal location is within a region of chromosome 21 which has been suggested to play a role in learning deficits associated with Down syndrome. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.874
BS2
High AC in GnomAd4 at 5 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OLIG2 | NM_005806.4 | c.868G>T | p.Gly290Cys | missense_variant | 2/2 | ENST00000382357.4 | NP_005797.1 | |
OLIG2 | XM_005260908.2 | c.868G>T | p.Gly290Cys | missense_variant | 2/2 | XP_005260965.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OLIG2 | ENST00000382357.4 | c.868G>T | p.Gly290Cys | missense_variant | 2/2 | 1 | NM_005806.4 | ENSP00000371794 | P1 | |
ENST00000454622.2 | n.201+43174C>A | intron_variant, non_coding_transcript_variant | 2 | |||||||
OLIG2 | ENST00000333337.3 | c.868G>T | p.Gly290Cys | missense_variant | 1/1 | ENSP00000331040 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151920Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
5
AN:
151920
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000197 AC: 2AN: 10148Hom.: 0 AF XY: 0.000152 AC XY: 1AN XY: 6564
GnomAD3 exomes
AF:
AC:
2
AN:
10148
Hom.:
AF XY:
AC XY:
1
AN XY:
6564
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000386 AC: 47AN: 1217510Hom.: 0 Cov.: 34 AF XY: 0.0000354 AC XY: 21AN XY: 592506
GnomAD4 exome
AF:
AC:
47
AN:
1217510
Hom.:
Cov.:
34
AF XY:
AC XY:
21
AN XY:
592506
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151920Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74238
GnomAD4 genome
AF:
AC:
5
AN:
151920
Hom.:
Cov.:
33
AF XY:
AC XY:
2
AN XY:
74238
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 18, 2022 | The c.868G>T (p.G290C) alteration is located in exon 2 (coding exon 1) of the OLIG2 gene. This alteration results from a G to T substitution at nucleotide position 868, causing the glycine (G) at amino acid position 290 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Pathogenic
D;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;M
MutationTaster
Benign
D;D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D
REVEL
Uncertain
Sift
Pathogenic
D;D
Sift4G
Pathogenic
D;D
Polyphen
D;D
Vest4
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at